NEW COMPREHENSIVE ONLINE PLATFORM:
What are falsified medicines? What is their impact? How to tackle this global challenge?
Read More
@WHA70 IFPMA Reception – Special focus on vaccines 25 May 2017
IMMUNIZATION AND PREVENTION: A LIFE-COURSE APPROACH FOR A HEALTHY AND PRODUCTIVE AGEING POPULATION ON THE OCCASION OF THE 70TH WORLD HEALTH ASSEMBLY WE CORDIALLY INVITE YOU TO PARTICIPATE IN OUR RECEPTION THURSDAY 25TH MAY 2017, 18:00-21:00 INTERCONTINENTAL HOTEL, GENEVA, CHEMIN DU PETIT-SACONNEX, 9
Read More
Biotherapeutics & the Next 70 Years: Delivering on their Potential for Patients Globally
IAPO & IFPMA's side-event at 70th World Health Assembly on 23rd May 2017 Taking collaborative and coordinated actions to improve access to biotherapeutics by 2030
Register Here
Partnerships and the SDGs: Accelerating Access to NCD Care
Access Accelerated side-event at 70th World Health Assembly on 23rd May 2017 at Intercontinental. We envision a future where no one dies prematurely from a treatable, preventable disease, and all people living with non-communicable diseases have access to affordable, quality care.
Read More
IFPMA Corporate Brochure - Committed to a Healthier Future
We hope you find this brochure informative to gain better understanding of the contributions of our industry. We are passionate about the role we play in finding effective and sustainable solutions to today’s most pressing health concerns and look forward to continuing the dialogue with our partners
Read More
Pharma by numbers
In a simple click, find out what we bring to your country and to the world! This platform features key data and statistics for global health and pharma contribution at country and global levels.
Read More
IFPMA HEALTH PARTNERSHIPS DIRECTORY
IFPMA hosts the Health Partnerships Directory, a continuously expanding online database that allows users to view, in depth, health partnerships from across the world that involve the research-based biopharmaceutical industry.
Read MoreIFPMA in Brief
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
Tackling Global health challenges
The research-based biopharmaceutical industry is proud to be playing its part in the quest to find effective and sustainable solutions to today’s most pressing health concerns.
Read More
Boosting Innovation and Access
The research-based biopharmaceutical industry is thinking creatively about its innovation and business models to meet new challenges, and is working in collaboration with different players from the scientific community.
Read More
Strengthening Regulatory Systems
Patients everywhere should be treated with high quality medicines and vaccines. Science-based guidelines provide direction for the development, manufacture, and supply of medicines.
Read More
Building trust
The healthcare community and the public must be confident that research-based biopharmaceutical industry and their employees, wherever they operate, communicate and act in an ethical and professional manner.
Read More
Discovering medicines and Vaccines
Never have people lived longer and never have so many children been saved from dying in the first years of life. Medicines and vaccines extend and improve the quality of life for many people.
Read More
Our Resources
The Globalisation of the Pharmaceutical Industry
Read More
The R&D-based biopharmaceutical industry at the forefront of addressing AMR
Read More
IFPMA & IFPW Supply chain session 2016 Global Health Forum - long version
The session that took place at 2016 GHF ‘Shaping a sound supply chain ecosystem’ gathered speakers from BMS, IFPW Walgreens Boots Alliance, ICRC and WHO. Moderated by Scrip’s Sukaina Virji. To find out more about the complexities of the pharmaceutical supply chain, to hear what experts think are the essential...
Read More
22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases
22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases Global, multi-stakeholder collaboration, called Access Accelerated, to be delivered in partnership with World Bank Group and Union for International Cancer Control (UICC) Initial three-year commitment will catalyze, develop, measure and replicate sustainable programs in...
Read More
Interview with Anders Vinther on medicines & vaccines shortages
Read More
ABPI, EFPIA, and IFPMA issue joint statement on AMR
ABPI, EFPIA and IFPMA issue joint statement following publication of the final report by the Review on AMR The Association of the British Pharmaceutical Industry (ABPI), the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) have today issued a joint...
Read MoreJoin IFPMA
There are many challenges in improving public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.
LEARN MOREOur Blog
Supply & demand: fighting falsified medicines on two fronts
As falsified medicines are debated this week at the World Health Assembly, IFPMA shares what the biopharmaceutical is doing to combat this risk to individual and public health. If there’s one place not to take a gamble, it’s on whether or not a medicine is real or falsified. Yet in the last weeks alone we’ve seen headlines pop up across the world as authorities...
Read More
Medicines are not luxury goods
I must admit I had been somewhat skeptical about the "WHO Fair Pricing Forum" held last week in Amsterdam. There were multiple reasons for my apprehension. One concern was clearly that the notion of “fair” is pretty much in the eye of the beholder, another was that none of the 300 expected participants had received any background documentation as the event date was coming...
Read More
Medical miracles call for “moonshot” mindsets
Over the course of my lifetime, human lifespan extended by three decades. Today we hope to lead healthy lives well into our 80s. Now I have to declare a vested interest in this topic: I am an aspiring role model for active and healthy ageing (I’m past 60 and look forward to working actively for a number of years to come). And I have also...
Read MoreLatest Tweets
@IFPMA @IFPMA @IFPMA @IFPMA 